Recombinant SARS-CoV-2 (B.1.617.2) Spike Glycoprotein RBD (L452R, T478K) (His tag) is a SARS-CoV-2 Fragment protein, in the 319 to 541 aa range, expressed in CHO, with >70% purity and suitable for SDS-PAGE, FuncS.
>70% SDS-PAGE
CHO cells
His tag C-Terminus
SDS-PAGE, FuncS
No
R V Q P T E S I V R F P N I T N L C P F G E V F N A T R F A S V Y A W N R K R I S N C V A D Y S V L Y N S A S F S T F K C Y G V S P T K L N D L C F T N V Y A D S F V I R G D E V R Q I A P G Q T G K I A D Y N Y K L P D D F T G C V I A W N S N N L D S K V G G N Y N Y R Y R L F R K S N L K P F E R D I S T E I Y Q A G S K P C N G V E G F N C Y F P L Q S Y G F Q P T N G V G Y Q P Y R V V V L S F E L L H A P A T V C G P K K S T N L V K N K C V N F
Application | Reactivity | Dilution info | Notes |
---|---|---|---|
Application SDS-PAGE | Reactivity Reacts | Dilution info - | Notes - |
Application FuncS | Reactivity Reacts | Dilution info - | Notes - |
Spike protein S1Attaches the virion to the cell membrane by interacting with host receptor, initiating the infection. The major receptor is host ACE2 (PubMed:32142651, PubMed:33607086, PubMed:32155444). When S2/S2' has been cleaved, binding to the receptor triggers direct fusion at the cell membrane (PubMed:34561887). When S2/S2' has not been cleaved, binding to the receptor results in internalization of the virus by endocytosis leading to fusion of the virion membrane with the host endosomal membrane (PubMed:32221306, PubMed:32075877). Alternatively, may use NRP1/NRP2 (PubMed:33082294, PubMed:33082293) and integrin as entry receptors (PubMed:35150743). The use of NRP1/NRP2 receptors may explain the tropism of the virus in human olfactory epithelial cells, which express these molecules at high levels but ACE2 at low levels (PubMed:33082293). The stalk domain of S contains three hinges, giving the head unexpected orientational freedom (PubMed:32817270).Spike protein S2Precursor of the fusion protein processed in the biosynthesis of the S protein and the formation of virus particle. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains two viral fusion peptides that are unmasked after cleavage. The S2/S2' cleavage occurs during virus entry at the cell membrane by host TMPRSS2 (PubMed:32142651) or during endocytosis by host CSTL (PubMed:32703818, PubMed:34159616). In either case, this triggers an extensive and irreversible conformational change leading to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed:34561887). Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes.Spike protein S2'Subunit of the fusion protein that is processed upon entry into the host cell. Mediates fusion of the virion and cellular membranes by functioning as a class I viral fusion protein. Contains a viral fusion peptide that is unmasked after S2 cleavage. This cleavage can occur at the cell membrane by host TMPRSS2 or during endocytosis by host CSTL (PubMed:32703818, PubMed:34159616). In either case, this triggers an extensive and irreversible conformational change that leads to fusion of the viral envelope with the cellular cytoplasmic membrane, releasing viral genomic RNA into the host cell cytoplasm (PubMed:34561887). Under the current model, the protein has at least three conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During fusion of the viral and target cell membranes, the coiled coil regions (heptad repeats) adopt a trimer-of-hairpins structure and position the fusion peptide in close proximity to the C-terminal region of the ectodomain. Formation of this structure appears to promote apposition and subsequent fusion of viral and target cell membranes.
Spike glycoprotein, S glycoprotein, E2, Peplomer protein
Recombinant SARS-CoV-2 (B.1.617.2) Spike Glycoprotein RBD (L452R, T478K) (His tag) is a SARS-CoV-2 Fragment protein, in the 319 to 541 aa range, expressed in CHO, with >70% purity and suitable for SDS-PAGE, FuncS.
Spike glycoprotein, S glycoprotein, E2, Peplomer protein
>70% SDS-PAGE
CHO cells
His tag C-Terminus
SDS-PAGE, FuncS
No
P0DTC2
No
SARS-CoV-2
pH: 7.5
Preservative: 1.02% Imidazole
Constituents: 95.79% Water, 1.75% Sodium chloride, 1.34% Sodium phosphate dibasic heptahydrate
R V Q P T E S I V R F P N I T N L C P F G E V F N A T R F A S V Y A W N R K R I S N C V A D Y S V L Y N S A S F S T F K C Y G V S P T K L N D L C F T N V Y A D S F V I R G D E V R Q I A P G Q T G K I A D Y N Y K L P D D F T G C V I A W N S N N L D S K V G G N Y N Y R Y R L F R K S N L K P F E R D I S T E I Y Q A G S K P C N G V E G F N C Y F P L Q S Y G F Q P T N G V G Y Q P Y R V V V L S F E L L H A P A T V C G P K K S T N L V K N K C V N F
Fragment
319 to 541
Recombinant
His tag C-Terminus
Liquid
Spike protein S1
Belongs to the betacoronaviruses spike protein family.
The cytoplasmic Cys-rich domain is palmitoylated. Palmitoylated spike proteins drive the formation of localized ordered cholesterol and sphingo-lipid-rich lipid nanodomains in the early Golgi, where viral budding occurs.
Dry Ice
-80°C
Upon delivery aliquot
Avoid freeze / thaw cycle
Delta variant (B.1.617.2): L452R, T478K
The SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain (RBD) commonly referred to as 'anti-RBD' or 'COVID-19 RBD' plays a critical role in the viral entry mechanism of the SARS-CoV-2 virus. The RBD is part of the larger Spike (S) glycoprotein which has a molecular mass of about 180 kDa. This RBD is located on the surface of the virus and is responsible for binding to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells. Expression of the RBD occurs in the Spike protein which is synthesized during the viral replication cycle in infected host cells.
The SARS-CoV-2 Spike Glycoprotein RBD initiates attachment to host cells by specifically binding to the ACE2 receptor facilitating viral entry. The RBD is part of a larger trimeric complex where each monomer consists of an S1 and S2 domain. The S1 domain which includes the RBD is important for receptor binding while the S2 domain aids in membrane fusion. By mediating these initial interactions with host cells the RBD dictates the entry and infectivity of the virus.
The interaction of the SARS-CoV-2 RBD with ACE2 is an important event in the entry pathways of the virus. This interaction triggers a cascade of events leading to endocytosis and viral replication. The virus utilizes the cellular machinery by hijacking the ACE2-mediated entry pathway which involves proteolytic processing by transmembrane protease serine 2 (TMPRSS2). The RBD's role connects closely with these proteins playing a vital part in both viral fusion and endocytosis pathways.
The RBD of the SARS-CoV-2 Spike Glycoprotein is directly connected to COVID-19 the disease caused by the SARS-CoV-2 virus. This domain is a target for neutralizing antibodies such as 'anti-RBD' which can block the interaction with ACE2 potentially preventing infection. Additionally the RBD is implicated in COVID-19-related syndromes and conditions including severe acute respiratory distress syndrome. The Spike glycoprotein's significant interaction with ACE2 plays a role in the pathogenesis of these conditions by facilitating viral entry and propagation.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
SDS-PAGE analysis of ab289719.
Binding ability of ab289719 measured in a functional ELISA, ab289719 binds Human ACE2 (19-740) protein.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com